A Data Science Central Community
© 2021 TechTarget, Inc.
Powered by
Badges | Report an Issue | Privacy Policy | Terms of Service
Most Popular Content on DSC
To not miss this type of content in the future, subscribe to our newsletter.
Other popular resources
Archives: 2008-2014 | 2015-2016 | 2017-2019 | Book 1 | Book 2 | More
Most popular articles
Comment Wall (2 comments)
You need to be a member of AnalyticBridge to add comments!
Join AnalyticBridge
Welcome to Statistical Consulting. I see that you have great experience in modeling, simulation and specialty designs such as adaptive methods. What is your experience with using adaptive methods when presenting the methods to the FDA? Are they open and willing to embrace these methods?
Best
Stephan
Stephan Ogenstad, PhD
President & CEO
Statogen Consulting, LLC
http://www.statogen-consulting.com